Uniqure Notches Bullish Initiation On Gene Therapy Prospects

By: via Benzinga
Uniqure NV (NASDAQ: QURE) has managed to win the seal of approval from Wells Fargo Securities due to its gene therapy pipeline ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.